Qiu Zhong

发表

Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors.

Jiawang Liu, Shanchun Guo, Shilong Zheng, 2018, ACS medicinal chemistry letters.

Development of a bioavailable boron-containing PI-103 Bioisostere, PI-103BE.

Shanchun Guo, Shilong Zheng, Guangdi Wang, 2020, Bioorganic & medicinal chemistry letters.

Proteomic Signatures of Acquired Letrozole Resistance in Breast Cancer: Suppressed Estrogen Signaling and Increased Cell Motility and Invasiveness*

Syreeta L. Tilghman, M. Bratton, Ian K. Townley, 2013, Molecular & Cellular Proteomics.

Discovery of a Series of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion.

M. Burow, Madhusoodanan Mottamal, Shilong Zheng, 2013, ACS medicinal chemistry letters.

Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast Cancer.

Shilong Zheng, Guangdi Wang, Quan Jiang, 2012, ACS medicinal chemistry letters.

Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer

L. Miele, Shilong Zheng, Guangdi Wang, 2015, Breast Cancer Research and Treatment.

Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD).

Jiawang Liu, Shanchun Guo, M. Bratton, 2016, Journal of medicinal chemistry.

Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator.

Jiawang Liu, Shanchun Guo, M. Bratton, 2017, ACS medicinal chemistry letters.

Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status

L. Miele, Shilong Zheng, Guangdi Wang, 2015, BMC Cancer.

ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models

M. Ellis, Yong Wu, R. Houtman, 2018, OncoTarget.

Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)

Jiawang Liu, Shanchun Guo, Shilong Zheng, 2017, Oncotarget.

Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition

Shanchun Guo, Ying Li, Shilong Zheng, 2016, Molecules.

Design, synthesis, and evaluation of a novel series of mono-indolylbenzoquinones derivatives for the potential treatment of breast cancer.

C. Chen, Shilong Zheng, Guangdi Wang, 2022, European journal of medicinal chemistry.

Design, Synthesis, and Antitumor Activity of a Series of Novel 4-(Aromatic Sulfonyl)-1-oxa-4-azaspiro[4.5]deca-6,9-dien-8-ones

Chen Chen, Shilong Zheng, Guangdi Wang, 2020, Molecules.

Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.

Shilong Zheng, Guangdi Wang, Amjad Hussain, 2014, European journal of medicinal chemistry.

Modification and Biological Evaluation of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion

J. Sridhar, Madhusoodanan Mottamal, Shilong Zheng, 2014, Journal of medicinal chemistry.

Chemoselective synthesis and cytotoxic activity of a series of novel benzo[1,4]oxazin-3-one derivatives

Shilong Zheng, Guangdi Wang, Ling He, 2017 .

Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.

Shilong Zheng, Guangdi Wang, Changde Zhang, 2015, Journal of medicinal chemistry.

Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach.

Shilong Zheng, Guangdi Wang, Qiu Zhong, 2015, European journal of medicinal chemistry.

Copper salt-catalyzed formation of a novel series of triazole-spirodienone conjugates with potent anticancer activity.

Shilong Zheng, Guangdi Wang, L. Gu, 2017, RSC advances.

Design, Synthesis, and Biological Evaluation of Novel Pyridine-Bridged Analogues of Combretastatin-A4 as Anticancer Agents

Madhusoodanan Mottamal, Shilong Zheng, Guangdi Wang, 2014, Journal of medicinal chemistry.

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

Steven Elliott, Guangdi Wang, E. Martin, 2012, Breast Cancer Research.

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

E. Martin, L. Rhodes, S. Elliott, 2012, Breast Cancer Research.

Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.

Shanchun Guo, Shilong Zheng, Guangdi Wang, 2017, European journal of medicinal chemistry.

Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.

Shilong Zheng, Guangdi Wang, Qiao-Hong Chen, 2016, European journal of medicinal chemistry.

Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability

Shanchun Guo, Shilong Zheng, Guangdi Wang, 2019, Pharmaceuticals.

Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors.

Shilong Zheng, Guangdi Wang, Ling He, 2023, Bioorganic chemistry.

Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer

Shanchun Guo, Florastina Payton-Stewart, M. Bratton, 2023, Pharmaceuticals.

Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach.

Shilong Zheng, Guangdi Wang, Qiu Zhong, 2015, European journal of medicinal chemistry.

Synthesis and Antitumor Activity of a Series of Novel 1-Oxa-4-azaspiro[4,5]deca-6,9-diene-3,8-dione Derivatives

Shilong Zheng, Guangdi Wang, Ling He, 2019, Molecules.